deoxypyridinoline has been researched along with Multiple Myeloma in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (38.89) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Hata, H; Iyama, K; Kawano, Y; Kikukawa, Y; Mitsuya, H; Okuno, Y; Ueno, S; Yuki, H | 1 |
| Diamond, TH; Golombick, T; Manoharan, A; Ramakrishna, R | 1 |
| Brux, B; Eucker, J; Heider, U; Jakob, C; Langelotz, C; Possinger, K; Sezer, O; Sinha, P; Zavrski, I | 1 |
| Abe, M; Hashimoto, T; Inoue, D; Matsumoto, T; Oshima, T; Ozaki, S; Shibata, H | 1 |
| Azaïs, I; Blanc, M; Brazier, M; Facon, T; Jamart, J; Jaubert, J; Kamel, S; Leleu, X; Mathiot, C; Samani, KK | 1 |
| Baccarani, M; Boni, P; Cangini, D; Cavo, M; Ceccolini, M; Cellini, C; Parente, R; Perrone, G; Tacchetti, P; Tosi, P; Tura, S; Zamagni, E | 1 |
| Barista, I; Celik, I; Cila, A; Dizdar, O; Hascelik, G; Kalyoncu, U; Karadag, O; Kars, A; Pinar, A; Tekuzman, G | 1 |
| Kapoor, S | 1 |
| Armbruster, FP; Horn, E; Karmatschek, M; Ludwig, H; Pecherstorfer, M; Seibel, MJ; Woitge, HW; Ziegler, R | 1 |
| Apperley, J; Girgis, S; Nawawi, H; Samson, D | 1 |
| Armbruster, FP; Karmatschek, M; Reinauer, H; Withold, W | 1 |
| Braun, HJ; Deicher, H; Fett, W; Harms, P; Kindler, U; Klinkenstein, C; Peest, D; Planker, M; Schäfer, E; Schumacher, K; Siecke, H | 1 |
| Cieslar, P; Hulejová, H; Klener, P; Slabý, J; Spacek, P; Spicka, I | 1 |
| Carlson, K; Larsson, A; Ljunghall, S; Simonsson, B; Turesson, I; Westin, J | 1 |
| Clark, RE; Durham, BH; Flory, AJ; Fraser, WD; Ion, EM; Woodcock, BE | 1 |
| Horiuchi, T; Hosoi, T; Ito, H; Ohta, M; Onouchi, T; Orimo, H; Shionoiri, A; Tsutsumi, H | 1 |
| Chrz, M; Cieslar, P; Hulejová, H; Klener, P; Procházka, B; Spacek, P; Spicka, I; Válková, V | 1 |
| Bayer, P; Diel, IJ; Horn, E; Keck, AV; Ludwig, H; Pecherstorfer, M; Seibel, MJ; Woitge, HW; Ziegler, R | 1 |
4 trial(s) available for deoxypyridinoline and Multiple Myeloma
| Article | Year |
|---|---|
Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.
Topics: Aged; Aged, 80 and over; Amino Acids; Antineoplastic Agents, Phytogenic; Biomarkers; Bone Remodeling; Creatinine; Cross-Over Studies; Curcumin; Disease Progression; Double-Blind Method; Female; Humans; Immunoglobulin Light Chains; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Myeloma Proteins; Parathyroid Hormone; Treatment Outcome; Vitamin D | 2012 |
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Remodeling; Bone Resorption; Collagen Type I; Dexamethasone; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Multiple Myeloma; Osteocalcin; Pain; Peptides; Thalidomide; Treatment Outcome; Zoledronic Acid | 2006 |
Pyridinium cross-links in multiple myeloma: correlation with clinical parameters and use for monitoring of intravenous clodronate therapy--a pilot study of the German Myeloma Treatment Group (GMTG).
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers, Tumor; Bone Resorption; Clodronic Acid; Collagen; Collagen Type I; Humans; Middle Aged; Multiple Myeloma; Neoplasm Staging; Paraneoplastic Syndromes; Peptides; Pilot Projects | 1996 |
[Effect of clodronate in patients with multiple myeloma. Evaluation of specific markers of bone resorption].
Topics: Adult; Aged; Amino Acids; Biomarkers; Bone Resorption; Clodronic Acid; Female; Humans; Male; Middle Aged; Multiple Myeloma | 1997 |
14 other study(ies) available for deoxypyridinoline and Multiple Myeloma
| Article | Year |
|---|---|
TRAIL produced from multiple myeloma cells is associated with osteolytic markers.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Calcium; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Male; Middle Aged; Multiple Myeloma; Osteolysis; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; TNF-Related Apoptosis-Inducing Ligand | 2012 |
Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Resorption; Collagen; Collagen Type I; Humans; Middle Aged; Multiple Myeloma; Paraproteinemias; Peptide Fragments; Peptides; Predictive Value of Tests; Procollagen; Prognosis | 2002 |
Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1alpha and MIP-1beta correlates with lytic bone lesions in patients with multiple myeloma.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Biomarkers; Chemokine CCL3; Chemokine CCL4; Female; Humans; Macrophage Inflammatory Proteins; Male; Middle Aged; Multiple Myeloma; Osteocalcin; Osteolysis; Tumor Cells, Cultured | 2004 |
Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma.
Topics: Aged; Amino Acids; Biomarkers; Bone Resorption; Collagen; Collagen Type I; Female; Humans; Male; Multiple Myeloma; Peptides; Predictive Value of Tests; Prognosis; Pyridinium Compounds; Retrospective Studies; Survival Analysis | 2005 |
Biochemical markers of bone turnover in diagnosis of myeloma bone disease.
Topics: Aged; Amino Acids; Biomarkers; Bone Density; Bone Diseases; Chemokine CCL3; Chemokine CCL4; Collagen Type I; Female; Humans; Macrophage Inflammatory Proteins; Magnetic Resonance Imaging; Male; Multiple Myeloma; Osteopontin; Peptides; Predictive Value of Tests | 2007 |
TGF-beta 1 and urinary excretion of pyridinium crosslinks: Two often overlooked risk factors for assessing risk of progression in patients with monoclonal gammopathy of undetermined significance.
Topics: Amino Acids; Bone Resorption; Diagnosis, Differential; Disease Progression; Humans; Multiple Myeloma; Paraproteinemias; Risk Factors; Transforming Growth Factor beta1; Ultrasonography | 2008 |
Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Diseases; Bone Resorption; Breast Neoplasms; Female; Humans; Hyperparathyroidism; Integrin-Binding Sialoprotein; Middle Aged; Multiple Myeloma; Osteitis Deformans; Radioimmunoassay; Reference Values; Sialoglycoproteins | 1996 |
Biochemical bone markers in patients with multiple myeloma.
Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Biomarkers, Tumor; Bone and Bones; Bone Resorption; Calcium; Creatinine; Female; Humans; Isoenzymes; Male; Middle Aged; Multiple Myeloma; Osteocalcin; Peptide Fragments; Procollagen; Sex Factors; Tartrate-Resistant Acid Phosphatase | 1996 |
Bone sialoprotein in serum of patients with malignant bone diseases.
Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Bone and Bones; Bone Neoplasms; Female; Humans; Integrin-Binding Sialoprotein; Isoenzymes; Kidney; Liver; Male; Middle Aged; Multiple Myeloma; Peptide Fragments; Postmenopause; Procollagen; Radioimmunoassay; ROC Curve; Sialoglycoproteins | 1997 |
Evaluation of bone disease in multiple myeloma: a comparison between the resorption markers urinary deoxypyridinoline/creatinine (DPD) and serum ICTP, and an evaluation of the DPD/osteocalcin and ICTP/osteocalcin ratios.
Topics: Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Diseases; Bone Resorption; Collagen; Collagen Type I; Creatinine; Female; Humans; Male; Middle Aged; Multiple Myeloma; Osteocalcin; Peptide Fragments; Peptides; Procollagen; Prognosis; Radiography; Survival Analysis | 1999 |
Biochemical markers of bone turnover following high-dose chemotherapy and autografting in multiple myeloma.
Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Remodeling; Bone Resorption; Carmustine; Clodronic Acid; Combined Modality Therapy; Cytarabine; Disease Progression; Female; Hematopoietic Stem Cell Transplantation; Humans; Isoenzymes; Male; Melphalan; Middle Aged; Multiple Myeloma; Osteoclasts; Peptide Fragments; Podophyllotoxin; Procollagen; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2000 |
Hypercalcemia induced with the plasma levels of parathyroid hormone-related peptide in multiple myeloma.
Topics: Aged; Amino Acids; Bone Marrow; Bone Resorption; Calcium; Cyclic AMP; Humans; Hypercalcemia; Interleukin-6; Kidney; Male; Multiple Myeloma; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Proteins; Transforming Growth Factor beta; Vitamin D | 2000 |
[Monitoring markers of bone turnover in multiple myeloma].
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Remodeling; Humans; Middle Aged; Multiple Myeloma; Osteocalcin; Paraproteinemias | 1999 |
Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Female; Humans; Integrin-Binding Sialoprotein; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Osteocalcin; Osteoporosis; Paraproteinemias; Prognosis; Radioimmunoassay; Sialoglycoproteins; Survival Analysis | 2001 |